NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

寡核苷酸合成的全球市場 - 成長率,趨勢及預測(2019年∼2024年)

Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 649746
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
寡核苷酸合成的全球市場 - 成長率,趨勢及預測(2019年∼2024年) Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 115 Pages
簡介

全球寡核苷酸合成市場,由於政府的投資及製藥公司和生物科技企業的研究開發費增加,以及分子診斷及臨床應用的合成寡核苷酸的有效利用等要素而成長。

本報告提供全球寡核苷酸合成市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊彙整。

目錄

第1章 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 政府投資及製藥、生物科技企業的研究開發費的增加
    • 分子診斷及臨床應用的合成寡核苷酸的有效利用
  • 市場阻礙因素
    • 合成寡核苷酸的價格下降
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/買方議價能力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭激烈度

第5章 市場區隔

  • 各產品類型
    • 合成寡核苷酸生成決裂
    • 各試劑
    • 各設備
  • 各應用領域
    • 各研究
    • 各診斷
    • 各治療
  • 各終端用戶
    • 學術研究機關
    • 製藥、生物科技企業
    • 診斷研究所
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Agilent Technologies
    • Thermo Fisher Scientific
    • Merck KGaA
    • Bio-Synthesis Inc.
    • Eurofins Genomics
    • Eurogentec
    • GE Healthcare
    • GenScript
    • Integrated DNA Technologies Inc.
    • LGC Biosearch Technologies

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 60475

The oligonucleotide synthesis market is expected to register a CAGR of 14.1% during the forecast period. The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.

  • The usage of synthetic oligonucleotides has been increasing rapidly over the past decade, owing to several benefits offered by molecular diagnostics and growing clinical applications. The nucleic acid application techniques are the reference methods, and they are very useful for carrying out the molecular diagnosis in several diseases, like for the detection of infectious diseases, such as hepatitis.
  • Synthetic oligonucleotides also have significant clinical applications, primarily for the detection of autoimmune antibodies. There have been consistent developments in synthetic biology over the past few years, where synthetic oligonucleotides were used to develop assays for the detection of anti-double-stranded DNAs. Thus, all these factors are responsible for the growth of the oligonucleotide synthesis market.
  • In addition, there are also other major factors influencing the market for oligonucleotide synthesis. These include the increasing advancement in the field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investments by the government for the development of genomic technologies, and the increasing demand for oligonucleotide synthesis technologies by the public and private research firms.

Key Market Trends

The Probes Segment is Expected to Grow during the Forecast Period

Oligonucleotide probes are short stretches of single-stranded DNA or RNA, primarily used to detect the presence of complementary nucleic acid sequences (target sequences) by hybridization.

They have wide applications in the life sciences industry. They are frequently used in the polymerization chain reaction (PCR) technique. In the real-time PCR technique, the DNA amount, if increased, can be observed and detected directly in real-time. This direct observation for quantification has raised new applications, particularly in diagnostics and validation, and is attained by using fluorescent dyes.

There are several types of probes, such as dual-labeled probes, double-quenched probes, fret probes, gene probes, etc. All of them have almost similar functions but are used for different applications.

North America is the Largest Growing Segment and is Expected to Follow the Same Trend Over the Forecast Period

North America dominates the market due to the presence of better healthcare infrastructure and the increasing usage of oligonucleotides by pharmaceutical companies in the region. Furthermore, the strong foothold of North America in genomics, proteomics, oncology, diagnostic screening, and drug discovery has significantly contributed to maintaining its large share. In the region, the United States is leading the market and is expected to continue the same over the forecast period.

Competitive Landscape

The companies are seen adopting various strategies that include the acquisition of players in the emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolios, which helps to drive the overall market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
    • 4.2.2 The Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
  • 4.3 Market Restraints
    • 4.3.1 Price Erosion of Synthesized Oligonucleotides
    • 4.3.2 Lack of Skilled Professionals and Research Support in Undeveloped Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Synthesized Oligonucleotide Products
    • 5.1.2 Reagents
    • 5.1.3 Equipment
    • 5.1.4 Services
  • 5.2 By Application
    • 5.2.1 Research
    • 5.2.2 Diagnostics
    • 5.2.3 Therapeutics
  • 5.3 By End User
    • 5.3.1 Academic Research Institutes
    • 5.3.2 Pharmaceutical and Biotechnology Companies
    • 5.3.3 Diagnostic Laboratories
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 GE Healthcare
    • 6.1.5 Bio-Synthesis Inc.
    • 6.1.6 Eurofins Genomics
    • 6.1.7 Eurogentec
    • 6.1.8 GenScript
    • 6.1.9 Integrated DNA Technologies Inc.
    • 6.1.10 LGC Biosearch Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS